ELTX

Elicio Therapeutics, Inc. - Common Stock (ELTX)

About Elicio Therapeutics, Inc. - Common Stock (ELTX)

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Details

Daily high

$5.10

Daily low

$4.76

Price at open

$4.94

52 Week High

$11.45

52 Week Low

$3.34

Market cap

75.9M

Dividend yield

0.00%

Volume

16,039

Avg. volume

45,265

P/E ratio

-1.07

Elicio Therapeutics, Inc. - Common Stock News